All In Biotech

Drug Trial Radar · NCT07644559

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

A Phase 2, Open-label Study of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and With Cetuximab, in Patients With Metastatic KRAS G12D-Mutated Pancreatic Cancer (TARGET-D 201)

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 185 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

185

Planned (sponsor's estimate)

Start

Jun 16, 2026

Primary completion

Jun 2027

Study completion Dec 2028

Sponsor

Lead sponsor
Verastem, Inc.Industry
Sponsor type
Industry
First posted
Jun 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic Cancer

Conditions

  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • G12D Mutated KRAS

Interventions

  • VS-7375Drug

    Taken by mouth

  • cetuximab (or panitumumab if α-gal IgE+ or cetuximab reaction)Drug

    Subcutaneous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed ORR by blinded independent central review (BICR) per RESIST v1.1Time frame: 6 months
  2. To characterize the safety and tolerability of VS-7375 monotherapy or in combination with cetuximab, administered on a daily oral schedule in participants with KRAS G12D-mutated PDAC.Time frame: 6 months

Locations

38 sites in 4 countries. Site status is shown where the registry gives one.

  • START- Los Angeles

    Los Angeles, California · Recruiting

  • Cedars-Sinai Medical Center

    Los Angeles, California · Recruiting

  • Valkyrie Clinical Trials

    Los Angeles, California · Recruiting

  • BRCR Global- Coral Springs

    Coral Springs, Florida · Recruiting

  • Mayo Clinical Florida

    Jacksonville, Florida · Recruiting

  • BRCR Global- Tamarac

    Tamarac, Florida · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

  • Johns Hopkins University

    Baltimore, Maryland · Recruiting

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

  • Dana-Farber Cancer Institute

    Boston, Massachusetts · Recruiting

  • University of Michigan

    Ann Arbor, Michigan · Recruiting

  • START Midwest

    Grand Rapids, Michigan · Recruiting

  • Mayo Clinical Rochester

    Rochester, Minnesota · Recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • START New Jersey

    East Brunswick, New Jersey · Recruiting

  • NYU-Manhattan

    New York, New York · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Recruiting

  • Sarah Cannon Research Institute

    Nashville, Tennessee · Recruiting

  • START Dallas

    Fort Worth, Texas · Recruiting

  • MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • START- San Antonio

    San Antonio, Texas · Recruiting

  • START- Mountain Region

    West Valley City, Utah · Recruiting

  • UVA Health

    Charlottesville, Virginia · Recruiting

  • Virginia Cancer Specialists

    Fairfax, Virginia · Recruiting

  • Virginia Mason

    Seattle, Washington · Recruiting

  • UW Health

    Madison, Wisconsin · Recruiting

  • ICON Cancer Centre

    South Brisbane, Australia · Recruiting

  • Macquarie University Hospital

    Sydney, New South Wales, Australia · Recruiting

  • Calvary Mater Newcastle

    Waratah, New South Wales, Australia · Recruiting

  • ICON Cancer Centre Townsville

    Hyde Park, Queensland, Australia · Recruiting

  • ICON Kurralta Park

    Kurralta Park, South Australia, Australia · Recruiting

  • ICON Cancer Centre- Hobart

    Hobart, Tasmania, Australia · Recruiting

  • Alfred Hospital

    Melbourne, Victoria, Australia · Recruiting

  • Sunnybrook Health Sciences Centre

    Toronto, Ontario, Canada · Recruiting

  • Princess Margaret Cancer Center

    Toronto, Ontario, Canada · Recruiting

  • BRCR Global- San Juan

    San Juan, Puerto Rico · Recruiting

  • BRCR- Yauco

    Yauco, Puerto Rico · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.